Expandable Venous Stents for Treatment of the Budd—Chiari Syndrome

Lopez, Rigoberto; Benner, Kent G.; Hall, Lee D.; Rösch, Josef; Pinson, C. Wright

doi:10.1016/0016-5085(91)70035-v

Cited by 51 publications

(20 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Reports on 21 patients treated with metal stents have been published in the literature to the best of our knowledge (Table 1) [4][5][6][7][8][9][10][11][12][13][14]. Either the IVC [5,6,9,10,11,14] or hepatic veins [4,8,12], or both [7] were stented. Intrahepatic venous connections allow decompression of venous outflow by restoring flow in the dominant hepatic vein only [4,7], as in our patient.…”

Section: Discussionmentioning

confidence: 99%

“…Either the IVC [5,6,9,10,11,14] or hepatic veins [4,8,12], or both [7] were stented. Intrahepatic venous connections allow decompression of venous outflow by restoring flow in the dominant hepatic vein only [4,7], as in our patient. No restenosis had occurred after follow-up of 3-44 months, but secondary thrombosis occurred twice at 3 months [12].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Treatment of Budd-Chiari syndrome by metallic stent as a bridge to liver transplantation

Martin¹,

Dondelinger²,

Trotteur³

1995

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

A 49-year-old male with Budd-Chiari syndrome complicated by liver cirrhosis and intractable ascites is reported. The left hepatic vein was stenosed by a short subocclusive ostial web; the right and medial hepatic veins were thrombosed. A spontaneous intrahepatic portosystemic shunt had developed between the left portal and left hepatic veins. After ineffective balloon angioplasty, the left hepatic venous outflow was restored by placement of a 10-mm-diameter Wallstent across the web via a femoral approach. The hepatic venous pressure dropped from 29 to 12 mmHg. Rapid clinical improvement followed. The patient underwent liver transplantation 3 months later in stable condition.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Treatment of Budd-Chiari syndrome by metallic stent as a bridge to liver transplantation

Martin¹,

Dondelinger²,

Trotteur³

1995

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

show abstract

“…Many therapeutic modalities 13,15,16 have been used to manage HVT, including thrombolysis 22 and/or angioplasty, [23][24][25] transjugular intrahepatic portosystemic shunt (TIPS), 26 surgical portosystemic shunt, and OLT. One-year survival reported in earlier studies with medical therapy alone ranged from 0% to 50%, 13,27 with the majority reporting approximately 33%, whereas survival with surgical therapy ranged from 61% to 100%.…”

Section: Discussionmentioning

confidence: 99%

Reassessing the role of medical therapy in the management of hepatic vein thrombosis

Min¹

1997

Liver Transplantation

View full text Add to dashboard Cite

SEE EDITORIAL ON PAGE 443Hepatic venous outflow obstruction caused by hepatic vein thrombosis (HVT) is a manifestation of a hypercoagulable state, most commonly a myeloproliferative disorder (MPD). In the past, HVT was thought to have a poor prognosis unless treated surgically with portosystemic shunt or orthotopic liver transplantation (OLT). The aim of this study was to assess whether early diagnosis of the underlying hematologic disorder and institution of appropriate medical therapy have altered outcome. We reviewed the charts of 22 patients with HVT evaluated at our center from January 1986 to January 1995. The median age was 32 years (range, 14 to 59 years). Underlying etiologies were MPD, 13 (polycythemia vera, 8; essential thrombocythemia, 4; undefined, 1); dysfibrinogenemia, 1; anticardiolipin antibody, 1; oral contraceptive use, 3; and idiopathic, 4. All patients had ascites, hepatomegaly, and/or abdominal pain. Two underwent mesocaval shunting, and 1 had a peritoneal-venous shunt. Seven patients, including 1 with a mesocaval shunt, underwent OLT. The median duration of symptoms before transplantation was 6 months (range, 1.5 to 11 months). Six transplant patients are alive on long-term anticoagulation therapy at a mean post-OLT follow-up of 42 months (range, 2 to 77 months), without recurrence. Of 13 patients treated medically, 10 (77%) are alive at a median follow-up of 40 months (range, 17 months to 14 years 8 months), 1 has died, and 2 have been lost to follow-up. In a majority of patients, symptoms improve with prompt treatment of the underlying hematologic disorder, with a favorable long-term prognosis. Patients with decompensated liver disease can successfully undergo OLT with a low risk of recurrence on long-term oral anticoagulation.

show abstract

“…She did not have recurrence of her SVC congestive syndrome until her death 11 months later. Since that time, we have treated more than 200 patients with SVC and IVC syndromes and obstructions of their large tributaries with metallic venous stenting (Lopez et al 1991;Rösch et al 1992). Similar experiences have been reported in the literature (Haage et al 1999;Oderich et al 2000;Raju et al 2002;Nael et al 2009).…”

Section: Introductionmentioning

confidence: 98%

Expandable Metallic Stents in Management of Large Vein Obstructions

Rösch

Keller

Kaufman

2014

PanVascular Medicine

Self Cite

View full text Add to dashboard Cite

The authors summarize their 26-year experience using expandable metallic stents for the management of large vein obstructions. After a short historic note and explanation of the etiologies of large vein obstructions, they describe various expandable stents and the results in using them for obstructions in large veins. For venous obstruction from malignant disease, stent placement was an excellent palliative treatment and provided relief in the majority of patients. In benign lesions, stent placement was a definitive long-term treatment for the patients' congestive symptoms. In venous obstructions related to arteriovenous dialysis shunts, stent deployment prolonged the life of the shunt.

show abstract

Expandable Venous Stents for Treatment of the Budd—Chiari Syndrome

Cited by 51 publications

References 13 publications

Treatment of Budd-Chiari syndrome by metallic stent as a bridge to liver transplantation

Treatment of Budd-Chiari syndrome by metallic stent as a bridge to liver transplantation

Reassessing the role of medical therapy in the management of hepatic vein thrombosis

Expandable Metallic Stents in Management of Large Vein Obstructions

Contact Info

Product

Resources

About